The Adaptive Cardio-Endocrine Network: A Critical Review of Bidirectional Heart–Endocrine Crosstalk from Physiological Adaptation to Disease

Ashraf T. Soliman *

Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.

Abdallah Mansour

Section Chair, Cardiovascular Medicine, Essentia Health Heart & Vascular Center, Fargo, ND, USA.a

Fawzia Alyafei

Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.

Nada Alaaraj

Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.

Noor Hamed

Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.

Shayma Ahmed

Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.

*Author to whom correspondence should be addressed.


Abstract

The heart is simultaneously a target of hormonal regulation and a secretory organ whose products act at a distance, yet cardiology and endocrinology continue to describe these two roles in largely separate literatures. This critical narrative review examines the evidence for bidirectional communication between the heart and the endocrine system, from reversible physiological adaptation to established disease, and asks how far an integrated network account is supported by current data. Literature was identified through structured searching of biomedical and multidisciplinary scholarly sources, supplemented by citation tracking and examination of recent reviews and clinical guidelines, with appraisal weighted towards mechanistic specificity, replication, and the distance between surrogate and clinical endpoints. Four themes emerge. First, natriuretic peptide biology provides the clearest example of an endocrine function of the heart, with reproducible lipolytic, thermogenic and insulin-sensitising actions in human tissue, although causal inference for metabolic protection rests mainly on genetic and animal evidence. Second, hormonal control of physiological cardiac growth during exercise, postnatal maturation and pregnancy is mechanistically well defined but has not translated into usable therapy. Third, endocrine disease produces recognisable and often reversible cardiac phenotypes, whereas the converse relationship, in which cardiac disease disturbs hormonal regulation, has generated prognostic associations that have repeatedly failed to become successful treatment targets. Fourth, drugs developed for metabolic indications now deliver some of the clearest cardiac benefits, which suggests that the therapeutic value of this axis lies in metabolic and mineralocorticoid signalling rather than in classical hormone replacement. Important uncertainties persist concerning the direction of causality in low-triiodothyronine states, the clinical meaning of natriuretic peptide deficiency in obesity, and the interpretation of cardiokines as hormones rather than stress biomarkers. The reviewed evidence supports a regulated network rather than a hierarchy, but confidence varies sharply between its components, and several widely repeated mechanistic claims remain supported largely by preclinical work.

Keywords: Natriuretic peptides, cardiokines, heart failure, thyroid hormone, aldosterone, neurohormonal activation, cardiometabolic disease


How to Cite

Soliman, Ashraf T., Abdallah Mansour, Fawzia Alyafei, Nada Alaaraj, Noor Hamed, and Shayma Ahmed. 2026. “The Adaptive Cardio-Endocrine Network: A Critical Review of Bidirectional Heart–Endocrine Crosstalk from Physiological Adaptation to Disease”. Journal of Advances in Medicine and Medical Research 38 (12):37-71. https://doi.org/10.9734/jammr/2026/v38i126252.

Downloads

Download data is not yet available.